Browse by People


Up a level
Export as [feed] RSS [feed] RSS 2.0 Short Author List
Number of items: 5.


Mazurek, Michal, Halperin, Jonathan L, Huisman, Menno V, Diener, Hans-Christoph, Dubner, Sergio J, Ma, Chang Sheng, Rothman, Kenneth J, Healey, Jeff S, Teutsch, Christine, Paquette, Miney
et al (show 4 more authors) (2020) Antithrombotic treatment for newly diagnosed atrial fibrillation in relation to patient age: the GLORIA-AF registry programme. EUROPACE, 22 (1). pp. 47-57.


Huisman, Menno V, Teutsch, Christine ORCID: 0000-0002-8494-2876, Lu, Shihai, Diener, Hans-Christoph, Dubner, Sergio J, Halperin, Jonathan L, Ma, Chang-Sheng, Rothman, Kenneth J, Lohmann, Ragna, Gurusamy, Venkatesh Kumar
et al (show 3 more authors) (2022) Dabigatran versus vitamin K antagonists for atrial fibrillation in clinical practice: final outcomes from Phase III of the GLORIA-AF registry. Clinical research in cardiology : official journal of the German Cardiac Society, 111 (5). pp. 548-559.


Beier, Lea ORCID: 0000-0003-1861-0635, Lu, Shihai, França, Lionel Riou, Marler, Sabrina, Lip, Gregory YH ORCID: 0000-0002-7566-1626, Huisman, Menno V, Teutsch, Christine, Halperin, Jonathan L, Zint, Kristina, Diener, Hans-Christoph
et al (show 8 more authors) (2022) Evolution of antithrombotic therapy for patients with atrial fibrillation: The prospective global GLORIA-AF registry program. PloS one, 17 (10). e0274237-.


Koziel, Monika, Mazurek, Michal, Teutsch, Christine, Diener, Hans-Christoph, Dubner, Sergio J, Halperin, Jonathan L, Ma, Chang-Sheng, Rothman, Kenneth J, Brandes, Axel, Paquette, Miney
et al (show 6 more authors) (2020) Persistence with Anticoagulation for Atrial Fibrillation: Report from the GLORIA-AF Phase III 1-Year Follow-up. JOURNAL OF CLINICAL MEDICINE, 9 (6). E1969-.


Mazurek, Michał, Teutsch, Christine, Diener, Hans-Christoph, Dubner, Sergio J, Halperin, Jonathan L, Ma, Chang-Sheng, Rothman, Kenneth J, Paquette, Miney, Zint, Kristina, França, Lionel Riou
et al (show 5 more authors) (2019) Safety and effectiveness of dabigatran at 2 years: Final outcomes from Phase II of the GLORIA-AF registry program. American heart journal, 218. pp. 123-127.

This list was generated on Sun Mar 17 08:01:18 2024 GMT.